Andrew J Boyle

Summary

Affiliation: University of Melbourne
Country: Australia

Publications

  1. ncbi Is it time to burst the "balloon" for high-risk patients?
    Sukesh C Burjonroppa
    Cardiology Division, Heart and Vascular Center, UCSF, San Francisco, CA 94143, USA
    J Invasive Cardiol 19:347-8. 2007
  2. ncbi Use of a continuous-flow device in patients awaiting heart transplantation
    Leslie W Miller
    University of Minnesota, Minneapolis, USA
    N Engl J Med 357:885-96. 2007
  3. ncbi Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-up
    Andrew J Boyle
    Department of Medicine, University of Melbourne, St Vincent s Hospital, Princes St, Fitzroy 3065, Victoria, Australia
    Int J Cardiol 109:21-7. 2006
  4. ncbi Additive effects of endothelial progenitor cells combined with ACE inhibition and beta-blockade on left ventricular function following acute myocardial infarction
    Andrew J Boyle
    University of Melbourne, Department of Medicine, St Vincent s Hospital, Fitzroy, Victoria, 3065, Australia
    J Renin Angiotensin Aldosterone Syst 6:33-7. 2005
  5. ncbi Inhibition of protein kinase C reduces left ventricular fibrosis and dysfunction following myocardial infarction
    Andrew J Boyle
    Department of Medicine, St Vincent s Hospital, University of Melbourne, Melbourne, Princes Street, Fitzroy 3065, Vic, Australia
    J Mol Cell Cardiol 39:213-21. 2005
  6. ncbi The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen
    Andrew M Wilson
    University of Melbourne, Department of Medicine, St Vincent s Hospital, Princes St, Fitzroy, Melbourne, Victoria 3065, Australia
    Int J Cardiol 106:291-7. 2006
  7. ncbi Catalytic degradation of vitamin D up-regulated protein 1 mRNA enhances cardiomyocyte survival and prevents left ventricular remodeling after myocardial ischemia
    Guosheng Xiang
    Department of Surgery, Columbia University Medical Center, New York, New York 10032, USA
    J Biol Chem 280:39394-402. 2005
  8. doi Early improvement in cardiac tissue perfusion due to mesenchymal stem cells
    Karl H Schuleri
    Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Am J Physiol Heart Circ Physiol 294:H2002-11. 2008
  9. ncbi Assessment of a novel angiographic image stabilization system for percutaneous coronary intervention
    Andrew J Boyle
    Division of Cardiology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    J Interv Cardiol 20:153-7. 2007
  10. ncbi Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy
    Luciano C Amado
    Department of Medicine, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    J Am Coll Cardiol 48:2116-24. 2006

Collaborators

Detail Information

Publications13

  1. ncbi Is it time to burst the "balloon" for high-risk patients?
    Sukesh C Burjonroppa
    Cardiology Division, Heart and Vascular Center, UCSF, San Francisco, CA 94143, USA
    J Invasive Cardiol 19:347-8. 2007
  2. ncbi Use of a continuous-flow device in patients awaiting heart transplantation
    Leslie W Miller
    University of Minnesota, Minneapolis, USA
    N Engl J Med 357:885-96. 2007
    ..Continuous-flow pumps are newer types of left ventricular assist devices developed to overcome some of these limitations...
  3. ncbi Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-up
    Andrew J Boyle
    Department of Medicine, University of Melbourne, St Vincent s Hospital, Princes St, Fitzroy 3065, Victoria, Australia
    Int J Cardiol 109:21-7. 2006
    ..These results demonstrate the feasibility of G-CSF mobilization, leukapheresis and intracoronary transfer of CD34+ stem cells in patients with CIHD, but longer-term studies are required to ensure that this protocol is safe and effective...
  4. ncbi Additive effects of endothelial progenitor cells combined with ACE inhibition and beta-blockade on left ventricular function following acute myocardial infarction
    Andrew J Boyle
    University of Melbourne, Department of Medicine, St Vincent s Hospital, Fitzroy, Victoria, 3065, Australia
    J Renin Angiotensin Aldosterone Syst 6:33-7. 2005
    ..Clinical trials using stem cell therapy in conjunction with standard medical treatment are warranted...
  5. ncbi Inhibition of protein kinase C reduces left ventricular fibrosis and dysfunction following myocardial infarction
    Andrew J Boyle
    Department of Medicine, St Vincent s Hospital, University of Melbourne, Melbourne, Princes Street, Fitzroy 3065, Vic, Australia
    J Mol Cell Cardiol 39:213-21. 2005
    ..PKC-inhibition with ruboxistaurin led to attenuation in both the pathological fibrosis and impaired cardiac function that follow experimental MI, suggesting a possible role for this agent in preventing post-infarction heart failure...
  6. ncbi The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen
    Andrew M Wilson
    University of Melbourne, Department of Medicine, St Vincent s Hospital, Princes St, Fitzroy, Melbourne, Victoria 3065, Australia
    Int J Cardiol 106:291-7. 2006
    ..We review the postulated roles of CRP in atherogenesis and prediction of vascular events, as well as discussing current recommendations for CRP testing in patients...
  7. ncbi Catalytic degradation of vitamin D up-regulated protein 1 mRNA enhances cardiomyocyte survival and prevents left ventricular remodeling after myocardial ischemia
    Guosheng Xiang
    Department of Surgery, Columbia University Medical Center, New York, New York 10032, USA
    J Biol Chem 280:39394-402. 2005
    ..Strategies to inhibit VDUP1 expression and/or function during acute ischemic events may be beneficial to cardiac functional recovery and prevention of left ventricular remodeling...
  8. doi Early improvement in cardiac tissue perfusion due to mesenchymal stem cells
    Karl H Schuleri
    Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Am J Physiol Heart Circ Physiol 294:H2002-11. 2008
    ..Cardiac MRI-based measures of blood flow may be a useful tool to predict a successful myocardial regenerative process after MSC treatment...
  9. ncbi Assessment of a novel angiographic image stabilization system for percutaneous coronary intervention
    Andrew J Boyle
    Division of Cardiology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    J Interv Cardiol 20:153-7. 2007
    ..We tested a novel system to stabilize angiographic images at the region of interest in order to assist during PCI...
  10. ncbi Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy
    Luciano C Amado
    Department of Medicine, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    J Am Coll Cardiol 48:2116-24. 2006
    ..The purpose of this study was to test the hypothesis, with noninvasive multimodality imaging, that allogeneic mesenchymal stem cells (MSCs) produce and/or stimulate active cardiac regeneration in vivo after myocardial infarction (MI)...
  11. ncbi Cardiac Stem Cell Therapy. Need for Optimization of Efficacy and Safety Monitoring
    Peter Oettgen
    Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02115, USA
    Circulation 114:353-8. 2006
  12. ncbi Is stem cell therapy ready for patients? Stem Cell Therapy for Cardiac Repair. Ready for the Next Step
    Andrew J Boyle
    Department of Medicine, Division of Cardiology, Institute for Cell Engineering, and Specialized Center for Cell Based Therapy, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Circulation 114:339-52. 2006
  13. doi Quantitative automated assessment of myocardial perfusion at cardiac catheterization
    Andrew J Boyle
    Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Am J Cardiol 102:980-7. 2008
    ..Further studies to assess the prognostic value of this technique are warranted...